Mumbai, February 12: The Indian arm of US-based drug-maker Eli Lilly plans to launch three injectible devices this year, one of them being an insulin pen to treat diabetes, a top company official said.
The company will launch the insulin pen, called Quick Pen over the next couple of months, its Chairman and Managing Director Sandeep Gupta told PTI here, adding that one more injectible would be launched for Type I diabetes later in the year and another to treat oesteopororis.
“We are launching three devices this year…two for treating diabetes and one for oesteoporosis. Quick Pen will be launched in April or May this year,” Gupta said.
The Quick Pens will be imported from the company’s manufacturing unit in the US, he said, without divulging the number of units it plans to release in the market initially.
–Agencies